CG Oncology, Inc. Common stockCGONNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-4141.14%
↑ 65% vs avg
Percentile
P75
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-11988.64%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -4141.14% | +58.9% |
| 2024 | -10064.44% | +63.0% |
| 2023 | -27172.55% | -47.3% |
| 2022 | -18445.55% | -15335.4% |
| 2021 | -119.50% | - |